Companies

Korro Bio, Inc. (KRRO) SEC filings

CIK 0001703647 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)6.4 M0
Net income (USD)-58.0 M-84.7 M
Diluted EPS (USD/shares)-12.48-53.08-227.42

Latest filings

FiledFormDescriptionPeriod
2026-10-228-K8-K items 8.01,9.012026-10-22
2026-10-058-K8-K items 8.01,9.012026-10-05
2026-09-15442026-09-11
2026-09-14144144
2026-09-14144144
2026-09-14442026-09-11
2026-09-11144144
2026-09-11144144
2026-09-11144144
2026-09-10442026-09-08
2026-09-09144144
2026-09-08144144
2026-08-28442026-08-26
2026-08-26144144
2026-08-26144144
2026-08-21442026-08-19
2026-08-19144144
2026-08-19144144
2026-08-198-K8-K items 8.012026-08-19
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-13442026-08-11
2026-08-13442026-08-06
2026-08-11144144
2026-08-11144144
2026-08-0610-Q10-Q2026-06-30

Forms on file (last 1,000): 4 297, 144 166, 8-K 93, 3 46, 424B3 27, 10-Q 21, SC 13G/A 19, SC 13G 16. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=KRRO (0.002 USD), /gw/filings/filings?ticker=KRRO&form=8-K, /gw/filings/facts?ticker=KRRO&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange